Researchers at the Max Planck Institute of Psychiatry have identified a brain‑state mechanism in which corticotropin‑releasing hormone (CRH) produced by oligodendrocyte progenitor cells (OPCs) helps guide nerve repair after injury by delaying the maturation of neighbouring cells. The finding, published in Cell Reports, centers on the idea that this neuropeptide slows OPC development to aid tissue repair and also influences myelin formation during normal brain development.
The brain’s white matter relies on myelin, an insulating layer that speeds electrical impulses along nerve fibres. Oligodendrocytes are the specialised cells that generate this myelin, and new oligodendrocytes arise from OPCs as the brain repairs itself after injury or during development. The maturation of OPCs into myelin‑producing oligodendrocytes must thus be tightly regulated to ensure cells survive and function properly.
CRH is a neuropeptide widely studied for its role in coordinating the body’s stress response via its receptor CRHR1. The researchers sought to understand whether this hormone might operate beyond traditional stress pathways, particularly in tissue repair after brain trauma.
In experiments using genetically engineered mice that carry a fluorescent marker signalling CRH expression, the team induced small brain injuries and tracked the cellular response. They found that CRH‑producing cells gathered around injury sites, with the first such cells detectable as early as 12 hours after injury.
By applying chemical stains to brain tissue, the researchers confirmed these glowing cells were not neurons but oligodendrocyte progenitor cells, marking an early and unusual secretory response to physical brain trauma.
Following the cells for more than four months revealed that they proliferated rapidly in the days after injury and subsequently differentiated into mature oligodendrocytes, which extended processes to form myelin sheaths around nearby nerve fibres and persisted for the entire observation period.
The team then mapped CRHR1 receptors to identify which nearby cells could receive the CRH signal. Using an alternative mouse strain highlighting receptor locations, they discovered a distinct population of OPCs expressing CRHR1, establishing a potential communication network within damaged tissue.
To probe the network’s function, researchers compared mice lacking CRH production in OPCs or lacking the CRHR1 receptor with normal controls following injury. In those altered mice, the receptor‑bearing OPCs matured into myelin‑producing cells much quicker than in normal animals, indicating that the CRH signal normally acts as a brake on maturation.
However, faster maturation did not necessarily equate to better outcomes. In cases of larger injuries, the rapid differentiation reduced the long‑term survival of oligodendrocytes, suggesting the injury environment’s oxidative stress makes the delayed maturation protective.
The study also explored whether this signalling network operates in healthy, uninjured brains. Researchers found that receptor‑bearing OPCs naturally increase in number as mice reach adulthood, and postnatal mice lacking CRHR1 formed oligodendrocytes earlier than usual, indicating the hormone system helps prevent premature maturation during normal development.
Brain imaging of adult mice lacking the receptor showed higher overall myelin content across multiple regions, including the corpus callosum. Electron microscopy further revealed a shift in myelin distribution: smaller nerve fibres carried disproportionately thicker myelin, while larger fibres received comparatively thinner sheaths, implying that this hormone network helps balance myelin distribution by fibre size.
The authors caution against linking these findings directly to psychological stress. While CRH is central to emotional stress responses, the study focuses on localized tissue signaling after physical trauma or during typical development, and does not claim that psychological stress alters myelin through this pathway.
Limitations include the global deletion of the receptor in the main knockout line, which means the receptor was absent in neurons as well as OPCs and could indirectly affect glial cell behaviour. The researchers say future work should use genetic models that delete CRHR1 specifically in oligodendrocyte progenitor cells and explore how this network responds to diseases that actively destroy myelin.
The study, Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development, was led by Clemens Ries, Tibor Stark, Benoit Boulat, Torben Ruhwedel, Jan Philipp Delling, Antonio Miralles Infante, Julia T. von Poblotzki, Alessandro Ulivi, Iven-Alex von Mücke-Heim, Simon Chang, Kenji Sakimura, Keiichi Itoi, Dennis B. Nestvogel, Alessio Attardo, Michael Czisch, Klaus-Armin Nave, Wiebke Möbius, Leda Dimou, and Jan M. Deussing.
